Fred Alger Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Fred Alger Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-168,170	Closed	-$6.68M	–	437
2026 Q1	$6.68M	Buy	168,170 +6,023	+4%	+$154K	0.03%	203
2025 Q4	$4.06M	Sell	162,147 -28,213	-15%	-$715K	0.02%	262
2025 Q3	$4.62M	Buy	190,360 +66,604	+54%	+$1.18M	0.02%	246
2025 Q2	$1.63M	Sell	123,756 -22,642	-15%	-$287K	0.01%	326
2025 Q1	$2.11M	Sell	146,398 -44,053	-23%	-$721K	0.01%	295
2024 Q4	$3.19M	Buy	190,451 +12,898	+7%	+$214K	0.02%	286
2024 Q3	$2.84M	Buy	177,553 +166,560	+1,515%	+$2.04M	0.01%	300
2024 Q2	$99.3K	Buy	+10,993	New	+$104K	﹤0.01%	402

Fred Alger Management's CNTA Position: Q2 2026 in Review

Fred Alger Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 168,170 shares — an estimated $6.68M sold.

Fred Alger Management first reported a position in CNTA in Q2 2024 and held it in 8 quarters. The position peaked at $6.68M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Fred Alger Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Fred Alger Management sold 168,170 Centessa Pharmaceuticals shares in Q2 2026, an estimated $6.68M.
Fred Alger Management first reported a position in Centessa Pharmaceuticals in Q2 2024 and held it in 8 quarters.
Fred Alger Management's Centessa Pharmaceuticals position peaked at $6.68M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.